Richard A. Gonzalez - 17 Jul 2024 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
EXECUTIVE CHAIRMAN OF BOARD, Director
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Richard A. Gonzalez
Issuer symbol
ABBV
Transactions as of
17 Jul 2024
Net transactions value
-$27,578,827
Form type
4
Filing time
19 Jul 2024, 16:40:53 UTC
Previous filing
02 Jul 2024
Next filing
07 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Options Exercise $5,341,388 +87,050 +17% $61.36* 600,149 17 Jul 2024 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $9,436,410 +119,418 +20% $79.02* 719,567 17 Jul 2024 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $7,141,250 +76,377 +11% $93.50 795,944 17 Jul 2024 Direct
transaction ABBV Common Stock, $0.01 par value Sale $49,497,875 -282,845 -36% $175.00 513,099 17 Jul 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right To Buy) Options Exercise $0 -87,050 -100% $0.000000* 0 17 Jul 2024 Common Stock 87,050 $61.36 Direct F1
transaction ABBV Option (Right To Buy) Options Exercise $0 -119,418 -67% $0.000000 59,709 17 Jul 2024 Common Stock 119,418 $79.02 Direct F1
transaction ABBV Option (Right To Buy) Options Exercise $0 -76,377 -33% $0.000000 152,755 17 Jul 2024 Common Stock 76,377 $93.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).